Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Randomized, Multicenter, Allopurinol-Controlled Study Assessing the Safety and Efficacy of Oral Febuxostat in Subjects With Gout

NCT02082769 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT02082769
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02082769 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Randomized, Multicenter, Allopurinol-Controlled Study Assessing the Safety and Efficacy of Oral Febuxostat in Subjects With Gout
Lead sponsor
Xijing Hospital
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2011
Completion date
October 31, 2013
Enrollment
504 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

gout